Skip to main content
CStone Pharmaceuticals logo

CStone Pharmaceuticals — Investor Relations & Filings

Ticker · 2616 ISIN · KYG2588M1006 LEI · 300300095A57F80T2461 HKEX Manufacturing
Filings indexed 3,374 across all filing types
Latest filing 2022-06-23 Director's Dealing
Country KY Cayman Islands
Listing HKEX 2616

About CStone Pharmaceuticals

http://www.cstonepharma.com

CStone Pharmaceuticals is an innovation-driven biopharmaceutical company focused on the research, development, and commercialization of anti-tumor drugs. The company is dedicated to addressing the unmet medical needs of cancer patients globally. Its core therapeutic focus is on innovative immuno-oncology and molecularly targeted therapies. The R&D pipeline is strategically balanced, featuring potential first-in-class or best-in-class assets, including Antibody-Drug Conjugates (ADC) and multi-specific antibodies. CStone has successfully launched four innovative drugs and secured multiple New Drug Application and indication approvals.

Recent filings

Filing Released Lang Actions
Disclosure of Dealings under Rule 22 of the Takeovers Code
Director's Dealing Classification · 100% confidence The document is a Public Disclosure Form dated 23 June 2022, reporting dealings in shares of Yankuang Energy Group Company Limited. It references Rule 22 of the Hong Kong Code on Takeovers and Mergers, indicating it relates to disclosures of securities transactions by parties connected to a possible offer. The content is a detailed report of share dealings, including purchase amounts and prices, which aligns with insider or director share transactions. There is no indication of a full report, financial statements, or earnings data. The document is short (1497 characters) and focused on share dealings by a connected party, fitting the definition of Director's Dealing (DIRS).
2022-06-23 English
An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section
Regulatory Filings Classification · 95% confidence The document is extremely short (242 characters) and serves as a notification that an announcement has been published elsewhere on the website. It does not contain financial data, meeting details, or specific corporate actions, but rather acts as a pointer to another document. Per the 'Menu vs Meal' rule, this is a Report Publication Announcement.
2022-06-22 English
Disclosure of Dealings under Rule 22 of the Takeovers Code
Major Shareholding Notification Classification · 95% confidence The document is a Public Disclosure Form dated 22 June 2022, reporting dealings in shares of Yankuang Energy Group Company Limited. It references Rule 22 of the Hong Kong Code on Takeovers and Mergers, indicating it is related to disclosure of securities dealings by an exempt principal trader connected with an offeror. The content is a detailed table of share dealings, including derivatives and resultant balances. There is no indication of a full financial report, earnings release, or management discussion. The document is a regulatory disclosure about share transactions related to a possible offer, fitting the category of Major Shareholding Notification or similar. Given the specific nature of share dealings disclosure under takeover rules, the best fitting category is Major Shareholding Notification (MRQ). The document length is short and focused on shareholding changes, not a full report or announcement of a report.
2022-06-22 English
Disclosure of Dealings under Rule 22 of the Takeovers Code
Director's Dealing Classification · 95% confidence The document is a Public Disclosure Form dated 22 June 2022, reporting dealings in shares of Yankuang Energy Group Company Limited. It references Rule 22 of the Hong Kong Code on Takeovers and Mergers, indicating it is related to disclosures of securities dealings by an exempt principal trader connected with an offeror. The content focuses on share transactions, quantities, prices, and nature of dealings, without any financial statements, management commentary, or report attachments. This matches the definition of a Director's Dealing or insider transaction report rather than a full financial report or announcement of voting results or capital changes.
2022-06-22 English
Disclosure of Dealings under Rule 22 of the Takeovers Code
Director's Dealing Classification · 95% confidence The document is titled 'Public Disclosure Form' and details securities dealings pursuant to Rule 22 of the Hong Kong Code on Takeovers and Mergers. It lists transactions involving derivatives and share dealings related to Yankuang Energy Group Company Limited. The content focuses on insider or related party transactions in shares and derivatives, which aligns with reporting of personal share transactions by company directors or connected parties. There is no indication of financial results, management discussion, or regulatory announcements beyond share dealings. The document length is short (2066 characters) and is a disclosure of dealings in shares, fitting the definition of Director's Dealing filings.
2022-06-21 English
Disclosure of Dealings under Rule 22 of the Takeovers Code
Director's Dealing Classification · 100% confidence The document is titled 'Public Disclosure Form' and details securities dealings related to shares of Yankuang Energy Group Company Limited. It references Rule 22 of the Hong Kong Code on Takeovers and Mergers, indicating it is a disclosure of share transactions by a party connected with an offeror. The content focuses on the purchase and sale of shares and other securities, including quantities, prices, and dates. This matches the definition of Director's Dealing filings, which report personal share transactions by company directors and executives or related parties. The document is short (2725 characters) and does not contain financial statements or management commentary, so it is not an annual or interim report or earnings release. It is not a general regulatory filing or announcement of a report but a specific disclosure of share dealings. Therefore, the correct classification is Director's Dealing (DIRS).
2022-06-21 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.